Supporting Teen Problem-Solving (STEPS) 3 year outcomes: Preventing diabetes-specific emotional distress and depressive symptoms in adolescents with type 1 diabetes.
Supporting Teen Problem-Solving (STEPS) 3 year outcomes: Preventing diabetes-specific emotional distress and depressive symptoms in adolescents with type 1 diabetes.
复制标题
DOI：
10.1037/ccp0000608
复制
发表时间：
2020-11
影响因子：
5.9
通讯作者：
Hood KK
中科院分区：
文献类型：
--
作者：
Weissberg-Benchell J;Shapiro JB;Bryant FB;Hood KK
本文报道了STePS多中心随机对照试验（RCT）的3年结局；报告STePS试验的总体影响，以及试验各组（恢复力促进干预[PRP T1D]与糖尿病教育干预[EI]）对糖尿病特异性情绪困扰和抑郁症状的差异影响。参与者包括264名年龄在14-18岁的芝加哥和旧金山1型糖尿病（T1D）青少年。两个干预组均持续4.5个月，分别在基线、干预后（4.5个月）和5次随访（距基线8、12、16、28和40个月）进行评估。采用潜在生长曲线模型（LGCM）对干预效果进行调查，分析干预前和干预后及随访时间点的结局变化的速率和形状。参与者的平均年龄为15.7岁，平均T1D持续时间为6.9年，平均基线HbA1c为9.1%。样本是多样化的，近35%的人认为自己是种族或少数民族，60%的人是女性。与EI参与者相比，PRP T1D参与者报告的糖尿病痛苦显著降低，且效应量随时间增加。在汇总样本中，有40%的青少年在基线时报告抑郁程度升高，而在干预后3年，只有23%的青少年报告抑郁程度升高。此外，PRP T1D参与者在基线后16至40个月的抑郁症状显著下降，而教育组的参与者则没有。三年结果评估的结果表明，PRP T1D对青少年的痛苦和抑郁症状有所减轻。
This article reports the 3-year outcomes for the STePS multi-site Randomized Control Trial (RCT); reporting the overall impact of the STePS trial, and the differential impact of each arm of the trial (a resilience promoting intervention [PRP T1D] versus a diabetes education intervention [EI]) on diabetes-specific emotional distress and depressive symptoms. Participants included 264 adolescents with type 1 diabetes (T1D), ages 14–18, in Chicago and San Francisco. Both intervention arms lasted 4.5 months and assessments were conducted at baseline, post-intervention (4.5 months), and five follow-up visits (8, 12, 16, 28 and 40 months from baseline). Intervention efficacy was investigated using latent growth curve modeling (LGCM) to analyze the rate and shape of change of outcomes from pre-intervention across post-intervention and follow-up time points. Mean age of participants was 15.7 years, mean T1D duration was 6.9 years, mean HbA1c at baseline was 9.1%. The sample was diverse with nearly 35% identifying as racial or ethnic minorities, and 60% were female. PRP T1D participants reported significantly lower diabetes distress compared to EI participants, and the effect size increased over time. For the pooled sample, while 40% of youth reported elevated distress at baseline, only 23% reported elevated distress 3 years post-intervention. Moreover, PRP T1D participants experienced a significant decline in depressive symptoms from 16 to 40 months post-baseline, while participants in the education arm did not. Results from the three-year outcomes assessment demonstrate the robust effects of PRP T1D in adolescents with declines in distress and depressive symptoms.
登录
查看更多内容
影响因子：
16.2
作者：
de Wit M;Delemarre-van de Waal HA;Bokma JA;Haasnoot K;Houdijk MC;Gemke RJ;Snoek FJ
通讯作者：
Snoek FJ
影响因子：
3.6
作者：
Jaser, Sarah S.;Whittemore, Robin;Grey, Margaret
通讯作者：
Grey, Margaret
影响因子：
3.6
作者：
Lewin, Adam B.;LaGreca, Annette M.;Silverstein, Janet H.
通讯作者：
Silverstein, Janet H.
影响因子：
16.2
作者：
Luyckx, Koen;Seiffge-Krenke, Inge
通讯作者：
Seiffge-Krenke, Inge
影响因子：
3.4
作者：
Hagger, Virginia;Hendrieckx, Christel;Speight, Jane
通讯作者：
Speight, Jane